Susquehanna Fundamental Investments LLC Makes New Investment in Oscar Health, Inc. (NYSE:OSCR)

Susquehanna Fundamental Investments LLC bought a new position in Oscar Health, Inc. (NYSE:OSCR - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 45,860 shares of the company's stock, valued at approximately $616,000.

Several other institutional investors also recently modified their holdings of the stock. JPMorgan Chase & Co. lifted its holdings in shares of Oscar Health by 348.7% during the 4th quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company's stock valued at $139,246,000 after buying an additional 8,051,379 shares during the last quarter. BIT Capital GmbH increased its position in shares of Oscar Health by 5,711.6% during the fourth quarter. BIT Capital GmbH now owns 4,473,853 shares of the company's stock worth $60,129,000 after acquiring an additional 4,396,872 shares in the last quarter. Hennessy Advisors Inc. lifted its position in shares of Oscar Health by 550.3% in the fourth quarter. Hennessy Advisors Inc. now owns 4,188,400 shares of the company's stock worth $56,292,000 after purchasing an additional 3,544,300 shares in the last quarter. Gilder Gagnon Howe & Co. LLC raised its stake in Oscar Health by 51.4% in the fourth quarter. Gilder Gagnon Howe & Co. LLC now owns 6,335,862 shares of the company's stock valued at $85,154,000 after buying an additional 2,151,256 shares during the period. Finally, Clearbridge Investments LLC acquired a new position in Oscar Health in the 4th quarter valued at $19,088,000. Institutional investors own 75.70% of the company's stock.

Wall Street Analyst Weigh In

Separately, Wells Fargo & Company downgraded shares of Oscar Health from an "overweight" rating to an "equal weight" rating and decreased their target price for the company from $20.00 to $16.00 in a research report on Thursday, March 13th. Two investment analysts have rated the stock with a sell rating, three have given a hold rating, two have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus price target of $20.21.

Oscar Health Stock Performance

NYSE:OSCR traded up $0.24 during mid-day trading on Thursday, reaching $17.26. 6,765,196 shares of the stock were exchanged, compared to its average volume of 4,028,276. The company has a 50 day simple moving average of $13.27 and a 200-day simple moving average of $14.62. Oscar Health, Inc. has a 1 year low of $11.20 and a 1 year high of $23.79. The stock has a market capitalization of $4.32 billion, a P/E ratio of -862.57 and a beta of 1.75. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR - Get Free Report) last posted its earnings results on Wednesday, May 7th. The company reported $0.92 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.83 by $0.09. The firm had revenue of $3 billion during the quarter, compared to the consensus estimate of $2.87 billion. Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. The company's revenue was up 42.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.62 EPS. Analysts anticipate that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.